Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for OCD after Ketamine Infusion
NCT00956085Phase 2Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Aug 2009
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of memantine in obsessive compulsive disorder (OCD), sponsored by New York State Psychiatric Institute. Started Aug 2009; status: completed.
02
Drugs
memantine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT00956085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00956085.